Non-Surgical Treatment for Joint Pain Near Me: The 8-Location Access Map That Gets Texas, Florida, and New York Patients Into Care Fast in 2026

Introduction: You’ve Decided — Now Find the Right Clinic Fast

Patients searching for non-surgical treatment for joint pain near me have already made a critical decision. They have moved past the research phase and are ready to act. This guide delivers exactly what they need: a geographic access map that connects them to qualified care without delay.

The scope of joint pain in the United States is substantial. More than 32 million American adults live with osteoarthritis, and up to 27% of all US adults have some form of arthritis. This is not a niche concern. It is a mainstream health challenge affecting tens of millions of people across every state.

This article introduces the “Distance-to-Decision” framework, a practical guide to Unicorn Bioscience’s 8 locations across Texas, Florida, and New York. Rather than offering generic treatment information, this resource identifies which clinic serves each geographic area, highlights the most common conditions treated in each region, and explains how patients can access same-day consultations and treatment when they qualify.

The article is organized by state and city. Readers in Texas can jump directly to the six Texas locations. Those in South Florida can navigate to the Boca Raton section, and New York patients can find details on the Manhattan clinic. Each section provides specific addresses, patient populations served, and the fastest pathway to treatment.

Why Non-Surgical Joint Care Is the Right First Step in 2026

Patients who choose non-surgical options are making an evidence-based decision supported by current research. A 2026 peer-reviewed perspective from the University of Copenhagen confirms that nonsurgical treatment remains relevant even for advanced osteoarthritis. Only a minority of diagnosed OA patients ultimately require joint replacement surgery.

Consider the numbers: over 600,000 knee replacement surgeries are performed annually in the United States. Yet Unicorn Bioscience’s clinical data suggests up to 80% of patients told they need total knee replacement may not actually require surgery. Patients in this situation may benefit from exploring regenerative medicine alternatives to knee replacement before committing to an invasive procedure.

The science supporting regenerative approaches continues to advance. In January 2026, Stanford Medicine researchers published a breakthrough study demonstrating that blocking the aging enzyme 15-PGDH can reverse cartilage loss in aging joints and prevent arthritis after knee injuries. Human cartilage samples from knee replacement surgeries responded positively to the treatment, signaling that regenerative therapies are at the leading edge of orthopedic science.

The economic argument is equally compelling. Osteoarthritis generates an estimated $65 billion per year in direct US healthcare costs. Surgical interventions carry extended recovery periods, surgical risks, and significant out-of-pocket expenses. Non-surgical alternatives offer a different pathway: minimally invasive procedures with faster recovery and lower total costs.

The CDC recommends multimodal, nonpharmacologic interventions as first-line treatments for chronic pain. This recommendation aligns with patient behavior: 87% of older adults with arthritis already use non-pharmacologic treatments to manage their symptoms. The shift toward non-surgical care is a mainstream trend, not a fringe option.

The Distance-to-Decision Framework: How Unicorn Bioscience’s 8-Location Network Works

The Distance-to-Decision concept is straightforward: the shorter the distance between a patient and a qualified non-surgical provider, the faster they move from pain to treatment.

Unicorn Bioscience operates 8 locations across three of the most populous states in the country. Six clinics serve Texas (Austin, Dallas, El Paso, Fort Worth, Houston, and San Antonio). One clinic serves South Florida (Boca Raton). One clinic serves New York (Manhattan). This multi-state footprint provides geographic coverage for tens of millions of potential patients.

The same-day pathway eliminates the weeks-long wait common at hospital-based orthopedic departments. Qualified patients can receive a consultation and imaging-guided injection treatment on the same day. Virtual consultations are available for patients who want to confirm candidacy before traveling to a clinic.

On Day 1, patients undergo an intake assessment and imaging review. The clinical team develops a personalized regenerative medicine protocol based on inflammation levels, age, injury type, current medications, and health goals. All injections use ultrasound or X-ray guidance for precision, consistent with the industry trend of AI-enabled ultrasound driving first-pass injection accuracy above 90%.

The treatment menu spans PRP (Platelet-Rich Plasma), stem cell therapy, BMAC (Bone Marrow Aspiration Concentrate), exosome therapy, hyaluronic acid injections, and peptide therapy. This comprehensive toolkit allows for customized protocols that single-modality competitors cannot match.

Regulatory transparency note: As of 2026, the FDA has not approved stem cell, PRP, or exosome products specifically for orthopedic conditions. However, substantial clinical evidence supports safety and efficacy when administered by qualified providers within FDA regulatory frameworks.

Texas Locations: Non-Surgical Joint Pain Treatment Across the Lone Star State

Texas presents a unique combination of factors that drive demand for non-surgical joint care. The state has a large, geographically dispersed population with a high proportion of active adults, athletes, and an aging demographic. Both early-onset OA from sports injuries and age-related degenerative joint disease are prevalent.

Six of Unicorn Bioscience’s eight locations are in Texas, making it the most accessible state in the network for non-surgical joint care.

Austin, TX: 2501 W William Cannon Dr STE 208

The Austin clinic serves South and Central Austin residents, including the tech-industry workforce, university community, and active outdoor enthusiasts. This younger-skewing demographic experiences high rates of sports-related knee and shoulder injuries.

Common conditions treated include knee ligament injuries, early-onset osteoarthritis, shoulder overuse injuries, and plantar fasciitis from Austin’s running culture. PRP for ligament and tendon injuries, hyaluronic acid for early knee OA, and exosome therapy for accelerated recovery are particularly relevant for this patient population. Patients seeking stem cell therapy in Austin, Texas will find this location well-equipped to address a wide range of joint conditions.

Dallas, TX: 6200 Lyndon B Johnson Fwy Suite 180

The Dallas clinic serves North Dallas, Addison, Farmers Branch, and the LBJ Freeway corridor. The patient mix includes corporate professionals, suburban families, and older adults with degenerative joint conditions.

Knee osteoarthritis, hip pain, and spine-related joint conditions are common in this population. BMAC and stem cell therapy for advanced knee OA, PRP for tendon and ligament conditions, and hyaluronic acid viscosupplementation address the full spectrum of patient needs.

El Paso, TX: 11240 Vista Del Sol Suite C

The El Paso clinic serves a geographically isolated region with limited access to specialized regenerative care. The patient population includes El Paso residents, cross-border patients from West Texas and southern New Mexico, and military veterans and active-duty personnel from Fort Bliss.

Knee and hip osteoarthritis are prevalent in the significant aging population. Military-related joint injuries represent a distinct patient segment. This location provides critical access for patients who would otherwise need to travel hours to reach a major metropolitan regenerative medicine clinic.

Fort Worth, TX: 3712 W 7th St

The Fort Worth clinic serves the Near Southside and Cultural District neighborhoods, as well as the broader Tarrant County population. The patient mix includes active adults, older residents with degenerative joint disease, and athletes.

Knee and hip OA, rotator cuff injuries, and ankle and foot conditions are common in this working-class, active population. Patients in western DFW are better served by the Fort Worth location than the Dallas clinic, reducing travel time significantly.

Houston, TX: 12121 Richmond Ave., Suite #312

The Houston clinic serves West Houston, the Energy Corridor, Westchase, and Sugar Land-adjacent residents. This large, diverse population includes energy industry professionals, a significant older demographic, and a highly active sports community.

Knee osteoarthritis, hip pain, and shoulder injuries are prevalent. The full treatment menu is available, including stem cell therapy in Houston, PRP, exosomes, BMAC, hyaluronic acid, and peptide therapy. Houston is the most populous Texas city, and this location serves the largest potential patient population of any Texas clinic in the network.

San Antonio, TX: 115 Gallery Cir Suite 101

The San Antonio clinic serves North San Antonio, Stone Oak, and the broader Bexar County population. The area includes a large military and veteran community from Joint Base San Antonio, a significant Hispanic population with higher rates of obesity-related OA, and a growing active adult demographic.

Knee and hip osteoarthritis are common, with military-related joint injuries representing a distinct patient segment. Non-surgical options are particularly valuable for patients who need to maintain physical readiness or return to duty. The regenerative orthopedics provider guide for San Antonio offers additional context for patients evaluating their care options in this region.

Florida Location: Non-Surgical Joint Pain Treatment in South Florida

Florida has one of the oldest median-age populations in the United States, with a massive retiree community and high prevalence of osteoarthritis and degenerative joint disease. The state also has a large active adult and recreational sports community. Pickleball, tennis, golf, and running injuries are common drivers of joint pain.

Boca Raton, FL: 200 Glades Rd #2

The Boca Raton clinic serves Boca Raton, Delray Beach, Boynton Beach, Deerfield Beach, and the broader Palm Beach County and northern Broward County population. This area has a high concentration of retirees and active older adults.

Knee and hip osteoarthritis are the most common conditions in this demographic. Shoulder pain from recreational sports and plantar fasciitis are also prevalent. Hyaluronic acid viscosupplementation, which has FDA clearance for knee OA and has been shown to reduce knee-replacement risk by 44% in large health-system studies, is particularly relevant for this patient population. Patients can learn more about hyaluronic acid treatment options and how they apply to knee and hip OA before their first visit.

Research from 2025 suggests that combining hyaluronic acid with PRP may offer synergistic benefits for patients with moderate OA who have not achieved adequate relief from single-agent treatment.

This is the only Florida location. Patients from Miami, Fort Lauderdale, and West Palm Beach are all within reasonable driving distance.

New York Location: Non-Surgical Joint Pain Treatment in Manhattan

New York City’s walkability culture means joint pain has an outsized impact on daily life. Knee, hip, and ankle conditions directly affect a patient’s ability to commute, work, and enjoy the city.

Manhattan, NY: 515 Madison Avenue #1205

The Manhattan clinic serves Midtown Manhattan residents and workers, Upper East Side and Upper West Side residents, and commuters from the tri-state area who work in or near Midtown.

Knee and hip osteoarthritis, runner’s knee and IT band syndrome from Central Park running culture, shoulder injuries from gym and recreational sports, and ankle conditions from urban walking are common in this population.

The 515 Madison Ave location is in the heart of Midtown, accessible by subway, bus, and on foot from major residential and commercial corridors. Lunch-hour or after-work appointments are feasible for working professionals.

The full treatment menu is available. PRP is particularly relevant for the younger, active New York patient demographic. Stem cell therapy and BMAC address more advanced OA cases.

The medical team includes training from Johns Hopkins, one of the most prestigious medical institutions in the country.

What Non-Surgical Joint Treatments Are Available at Every Location

All eight Unicorn Bioscience locations offer a consistent treatment menu, ensuring patients receive the same quality of care regardless of which clinic they visit.

PRP (Platelet-Rich Plasma) Therapy

PRP therapy uses concentrated platelets derived from the patient’s own blood, injected into the affected joint to accelerate healing. A 2025 meta-analysis of 56 randomized controlled trials confirmed PRP is superior to both placebo and corticosteroids for chronic joint pain at 6- and 12-month follow-ups.

PRP results typically last 6 to 18 months. High-platelet PRP provides superior and more durable pain relief. Best applications include knee OA, tendon injuries, ligament tears, rotator cuff conditions, and plantar fasciitis.

Stem Cell Therapy and BMAC

Stem cell therapy and BMAC (Bone Marrow Aspiration Concentrate) are regenerative treatments using the body’s own cellular machinery to promote tissue repair. Unicorn Bioscience reports that more than 90% of stem cell patients have not gone on to knee replacement surgery.

Currently, 224 clinical trials globally are investigating stem cell therapies for osteoarthritis, and a $140 million Phase III clinical trial was announced in January 2026. These treatments are best suited for advanced knee and hip OA and for patients who have been told they need joint replacement surgery.

Hyaluronic Acid (Viscosupplementation)

Viscosupplementation uses hyaluronic acid injections to lubricate the joint and reduce pain. This is the only FDA-cleared injectable therapy specifically for knee osteoarthritis. Viscosupplementation holds approximately 47 to 48% of joint pain injection market revenue, making it the most widely used injectable therapy.

Large health-system studies show single-injection protocols reduced knee-replacement risk by 44%. Best applications include knee OA and hip OA, particularly for patients seeking an FDA-cleared option with a strong evidence base.

Exosome Therapy and Peptide Therapy

Exosome therapy uses extracellular vesicles that facilitate cellular communication and promote regeneration. Peptide therapy uses targeted peptide sequences that signal tissue repair. A 2025 comprehensive review of 59 clinical trials evaluated PRP, mesenchymal stem cells, peptide-based treatments, and biomimetic materials for orthopedic pain reduction.

These treatments are best for patients seeking cutting-edge regenerative options, or those who have not responded adequately to PRP or hyaluronic acid alone. All injections at Unicorn Bioscience are delivered with ultrasound or X-ray guidance for precision.

Which Joint Conditions Qualify for Non-Surgical Treatment?

The following conditions are treated across all eight locations:

Knee conditions: Osteoarthritis, meniscus injuries, ligament tears (ACL, MCL), runner’s knee, patellar tendinitis

Hip conditions: Hip osteoarthritis, labral tears, bursitis

Shoulder conditions: Rotator cuff injuries, shoulder OA, biceps tendinitis, AC joint pain

Elbow, wrist, and hand: Tennis elbow, golfer’s elbow, carpal tunnel-related joint pain, thumb OA

Ankle and foot: Plantar fasciitis, Achilles tendinopathy, ankle OA

Spine and neck: Facet joint pain, cervical and lumbar OA

Knee osteoarthritis is the most common joint condition, representing 60 to 85% of all OA cases. The lifetime risk of developing symptomatic knee OA is approximately 45%.

A personalized assessment at any Unicorn Bioscience location determines the most appropriate treatment protocol based on the patient’s specific condition, inflammation levels, age, and health goals.

What to Expect on Your First Visit: The Same-Day Pathway Explained

The patient journey from first contact to treatment follows a clear pathway:

Step 1: Contact the clinic by calling (737) 347-0446 or visiting unicornbioscience.com to schedule a consultation. Virtual consultations are available as a first step.

Step 2: The clinical team reviews medical history, imaging, inflammation levels, current medications, and health goals during the candidacy assessment.

Step 3: A personalized treatment plan is developed based on the patient’s specific condition and individual factors.

Step 4: Qualified patients receive ultrasound-guided injection treatment on the same day as the consultation.

Step 5: Outcomes are tracked during follow-up to assess response and adjust the protocol as needed.

This pathway is available at all eight locations. Patients do not need to wait weeks for a surgical consultation or navigate a hospital referral system. Industry data shows ambulatory surgery centers offer 40 to 60% lower episode costs than hospitals for injection procedures.

Frequently Asked Questions About Non-Surgical Joint Pain Treatment

How quickly can I be seen at a Unicorn Bioscience location?

Consultations can be scheduled promptly, and qualified patients can receive treatment on the same day as their consultation. Virtual consultations are available for patients who want to confirm candidacy before visiting a clinic in person. Contact the clinic at (737) 347-0446 or visit unicornbioscience.com to schedule.

Are non-surgical joint treatments covered by insurance?

Insurance coverage for regenerative treatments varies. Hyaluronic acid (viscosupplementation) has FDA clearance for knee OA and is covered by Medicare and many private insurers. PRP, stem cell therapy, exosomes, and BMAC are generally not covered by insurance as of 2026. Out-of-pocket costs for PRP typically range from approximately $500 to $2,500 per session.

The cost of non-surgical treatment is often significantly lower than the total cost of joint replacement surgery, rehabilitation, and lost work time.

How long do non-surgical joint treatments last?

PRP results typically last 6 to 18 months. High-platelet PRP provides more durable relief. Hyaluronic acid injections typically provide relief for 6 months or longer. Radiofrequency ablation benefits last 8 months to a year. Stem cell and BMAC outcomes vary by patient. Results depend on condition severity, patient age, activity level, and the specific treatment protocol used.

Am I a candidate for non-surgical treatment?

Most patients with osteoarthritis, tendon injuries, ligament conditions, and chronic joint pain are candidates for at least one non-surgical treatment modality. Even patients who have been told they need joint replacement surgery may be candidates. Virtual consultations are available for patients who want a preliminary assessment before visiting a clinic.

Conclusion: Your Nearest Unicorn Bioscience Location Is Ready

Non-surgical joint pain treatment is not only effective; it is now more accessible than ever. Eight Unicorn Bioscience locations across Texas, Florida, and New York are ready to see patients quickly.

The Distance-to-Decision framework is simple: the closer patients are to a qualified provider, the sooner they can begin treatment and start recovering.

Texas locations: Austin, Dallas, El Paso, Fort Worth, Houston, San Antonio

Florida location: Boca Raton

New York location: Manhattan

Same-day treatment is available for qualified patients at every location. The science supporting non-surgical joint care has never been stronger, from the Stanford cartilage regeneration breakthrough to the 2025 PRP meta-analysis.

Patients who choose non-surgical care are making an evidence-based, forward-looking decision. The right clinic is closer than they think.

Book a Consultation at the Nearest Unicorn Bioscience Location

Call (737) 347-0446 today to schedule a consultation at the Unicorn Bioscience location nearest you. Same-day appointments are available for qualified patients.

Visit unicornbioscience.com to book a virtual consultation and confirm candidacy before an in-person visit.

All 8 Locations:

• Austin: 2501 W William Cannon Dr STE 208, Austin, TX 78745
• Dallas: 6200 Lyndon B Johnson Fwy Suite 180, Dallas, TX 75240
• El Paso: 11240 Vista Del Sol Suite C, El Paso, TX 79936
• Fort Worth: 3712 W 7th St, Fort Worth, TX 76107
• Houston: 12121 Richmond Ave., Suite #312, Houston, TX 77082
• San Antonio: 115 Gallery Cir Suite 101, San Antonio, TX 78258
• Boca Raton: 200 Glades Rd #2, Boca Raton, FL 33432
• Manhattan: 515 Madison Avenue #1205, New York, NY 10022

Joint pain does not improve on its own. The sooner treatment begins, the better the likely outcomes.

Unicorn Bioscience’s team, trained at institutions including Johns Hopkins, is ready to build a personalized non-surgical treatment plan for every patient who walks through the door.